DrugCite
Search

ARIMIDEX

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Arimidex Adverse Events Reported to the FDA Over Time

How are Arimidex adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Arimidex, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Arimidex is flagged as the suspect drug causing the adverse event.

Most Common Arimidex Adverse Events Reported to the FDA

What are the most common Arimidex adverse events reported to the FDA?

Arthralgia
1285 (4.15%)
Hot Flush
841 (2.71%)
Fatigue
491 (1.58%)
Pain In Extremity
461 (1.49%)
Insomnia
400 (1.29%)
Weight Increased
396 (1.28%)
Alopecia
383 (1.24%)
Nausea
374 (1.21%)
Headache
371 (1.2%)
Arthritis
361 (1.17%)
Pain
355 (1.15%)
Show More Show More
Bone Pain
338 (1.09%)
Depression
322 (1.04%)
Asthenia
321 (1.04%)
Myalgia
299 (.97%)
Dizziness
289 (.93%)
Fall
284 (.92%)
Oedema Peripheral
262 (.85%)
Back Pain
257 (.83%)
Malaise
231 (.75%)
Hypoaesthesia
219 (.71%)
Gait Disturbance
207 (.67%)
Drug Dose Omission
199 (.64%)
Dyspnoea
199 (.64%)
Hypertension
199 (.64%)
Paraesthesia
199 (.64%)
Cough
198 (.64%)
Muscle Spasms
198 (.64%)
Neoplasm Malignant
194 (.63%)
Osteoporosis
192 (.62%)
Blood Cholesterol Increased
185 (.6%)
Diarrhoea
179 (.58%)
Breast Cancer
170 (.55%)
Musculoskeletal Stiffness
170 (.55%)
Weight Decreased
169 (.55%)
Ill-defined Disorder
162 (.52%)
Death
152 (.49%)
Carpal Tunnel Syndrome
151 (.49%)
Muscular Weakness
147 (.47%)
Trigger Finger
139 (.45%)
Anxiety
137 (.44%)
Blood Pressure Increased
129 (.42%)
Feeling Abnormal
127 (.41%)
Rash
126 (.41%)
Joint Stiffness
122 (.39%)
Arthropathy
120 (.39%)
Osteopenia
118 (.38%)
Musculoskeletal Pain
115 (.37%)
Neuropathy Peripheral
115 (.37%)
Constipation
114 (.37%)
Pruritus
114 (.37%)
Hyperhidrosis
113 (.36%)
Dry Mouth
109 (.35%)
Joint Swelling
109 (.35%)
Amnesia
107 (.35%)
Osteoarthritis
105 (.34%)
Cataract
102 (.33%)
Oropharyngeal Pain
99 (.32%)
Adverse Drug Reaction
96 (.31%)
Memory Impairment
96 (.31%)
Pneumonia
95 (.31%)
Vulvovaginal Dryness
92 (.3%)
Mood Swings
91 (.29%)
Night Sweats
91 (.29%)
Bone Density Decreased
88 (.28%)
Mood Altered
88 (.28%)
Vomiting
87 (.28%)
Drug Ineffective
85 (.27%)
Decreased Appetite
83 (.27%)
Chest Pain
80 (.26%)
Nasopharyngitis
80 (.26%)
Diabetes Mellitus
79 (.26%)
Urinary Tract Infection
77 (.25%)
Vaginal Haemorrhage
77 (.25%)
Tendonitis
76 (.25%)
Vision Blurred
75 (.24%)
Dry Skin
73 (.24%)
Neck Pain
73 (.24%)
Abdominal Pain Upper
71 (.23%)
Dry Eye
70 (.23%)
Gastrooesophageal Reflux Disease
70 (.23%)
Tremor
70 (.23%)
Burning Sensation
69 (.22%)
Myocardial Infarction
69 (.22%)
Abdominal Discomfort
67 (.22%)
Thrombosis
66 (.21%)
Pyrexia
65 (.21%)
Abdominal Distension
64 (.21%)
Adverse Event
64 (.21%)
Anaemia
63 (.2%)
Drug Interaction
63 (.2%)
Hair Growth Abnormal
62 (.2%)
Interstitial Lung Disease
62 (.2%)
Bone Disorder
61 (.2%)
Dyspepsia
61 (.2%)
Rheumatoid Arthritis
61 (.2%)
Abdominal Pain
60 (.19%)
Breast Cancer Recurrent
60 (.19%)
Osteonecrosis
59 (.19%)
Confusional State
58 (.19%)
Dysgeusia
58 (.19%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Arimidex, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Arimidex is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Arimidex

What are the most common Arimidex adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Arimidex, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Arimidex is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Arimidex According to Those Reporting Adverse Events

Why are people taking Arimidex, according to those reporting adverse events to the FDA?

Breast Cancer
4944
Breast Cancer Female
696
Breast Cancer Metastatic
177
Drug Use For Unknown Indication
105
Neoplasm Malignant
71
Breast Cancer Stage I
65
Show More Show More
Breast Cancer Recurrent
65
Prophylaxis
53
Product Used For Unknown Indication
49
Metastases To Bone
41
Breast Cancer Stage Ii
40
Breast Cancer In Situ
33
Breast Cancer Stage Iii
29
Breast Cancer Stage Iv
29
Ovarian Cancer
16
Hormone Therapy
16
Mastectomy
15
Breast Neoplasm
13
Breast Cancer Male
12
Chemotherapy
11
Neoplasm Prophylaxis
10
Oestrogen Receptor Assay Positive
9
Adjuvant Therapy
9
Gynaecomastia
8
Endometriosis
8
Hormone Replacement Therapy
8
Antioestrogen Therapy
7
Life Expectancy Shortened
7
Blood Testosterone Decreased
6
Lung Neoplasm Malignant
5
Oestrogen Therapy
5
Breast Lump Removal
5
Hormone Suppression Therapy
5
Malignant Breast Lump Removal
4
Progesterone Receptor Assay Positiv...
4
Metastasis
4
Inflammatory Carcinoma Of The Breas...
4
Ill-defined Disorder
4
Metastases To Lymph Nodes
3
Radiotherapy
3
Endocrine Disorder
3
Fracture
3
Bone Neoplasm Malignant
3
Drug Therapy
3
Carcinoma
3
Adverse Reaction
3
Adrenogenital Syndrome
3
Neoplasm Recurrence
3
Hormone Level Abnormal
3
Peutz-jeghers Syndrome
3
Prophylactic Chemotherapy
3

Drug Labels

LabelLabelerEffective
ArimidexAstraZeneca Pharmaceuticals LP27-APR-11
ArimidexPhysicians Total Care, Inc.01-FEB-12

Arimidex Case Reports

What Arimidex safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Arimidex. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Arimidex.